1 97

Printify

Magnetic Phone Case (Sky Info QR Code)

Magnetic Phone Case (Sky Info QR Code)

$25.00 USD
$25.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Surface

Protect your phone with purpose using the Hope Shield Magnetic Case—a blend of aesthetics, functionality, and impact. This custom case provides dual-layer protection with an outer polycarbonate shell and inner black TPU lining, designed to be flexible, durable, and impact-resistant. Available in a matte or glossy finish, it also includes an embedded magnet module, making it compatible with MagSafe® accessories for ultimate convenience.

Beyond safeguarding your device, 40% of all revenue from the Hope Shield Magnetic Case goes to Sky Foundation, a non-profit that funds pancreatic cancer research, so every purchase supports life-saving initiatives with style and purpose.

 

  • Dual-layer case for enhanced durability and protection
  • Outer shell: 100% polycarbonate; Inner lining: black TPU for cushioning (color/texture may vary slightly)
  • Available in premium matte or glossy finish
  • Full-wrap print for edge-to-edge design
  • Embedded MagSafe®-compatible magnet (non-Apple brand charger compatibility not guaranteed)
  • Built to be durable, flexible, and impact-resistant
View full details

Recent News

View all
  • Phase 1/2 Trial Launches for Innovative Pancreatic Cancer Immunotherapy

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

  • FDA Approves NALIRIFOX as First-Line Treatment for Metastatic Pancreatic Cancer

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

  • Immunotherapy for Pancreatic Ductal Adenocarcinoma: Barriers and Opportunities

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

1 3
View all